Contents
Do GWAS use statistical methods?
The results used in meta-analyses can be test statistics or effect sizes. GWAS researchers have also converted the individual test statistics into z scores31,32,36,37 and used odds ratios when the phenotype is dichotomous38 and regression coefficients when the phenotype is continuous.
What have GWAS shown us about the genetic basis of complex polygenic disease?
GWAS have consistently demonstrated that most common diseases and traits are highly polygenic, with a large number of underlying genetic variants that affect the disease or trait [39].
What is the main purpose of genome-wide association studies GWAS?
The genome-wide association study (GWAS) is a study design used to detect associations between genetic variants and common diseases or traits in a population.
How does knowing the sequence of the human genome make a GWAS feasible?
Because the sequence of the human genome is known, it is possible to search the entire genome for sites where genetic variation differs between populations, giving clues to why phenotypes within populations exist. GWAS is the study of variation across a genome between populations.
What is GWAS summary statistics?
GWAS summary statistics refer to supplying three important pieces of information: SNP, Phenotype, and P-value. This differs from full GWAS data which would have calls for every individual at every SNP.
How many GWAS studies are there?
As of 2017, over 3,000 human GWA studies have examined over 1,800 diseases and traits, and thousands of SNP associations have been found.
What are examples of complex diseases?
Some examples include Alzheimer’s disease, scleroderma, asthma, Parkinson’s disease, multiple sclerosis, osteoporosis, connective tissue diseases, kidney diseases, autoimmune diseases, and many more (Hunter, 2005). Scientists now know that complex diseases do not obey the standard Mendelian patterns of inheritance.
Why are genome-wide association studies difficult?
However, it is also possible that complex interactions among two or more SNPs, epistasis, might contribute to complex diseases. Due to the potentially exponential number of interactions, detecting statistically significant interactions in GWAS data is both computationally and statistically challenging.
What is a limitation of GWAS?
“GWAS have many limitations, such as their inability to fully explain the genetic/familial risk of common diseases; the inability to assess rare genetic variants; the small effect sizes of most associations; the difficulty in figuring out true causal associations; and the poor ability of findings to predict disease …
What is effect size in GWAS?
Typical GWAS odds ratios are about 1.1–1.2. For quantitative traits, such as height or weight, the size of the effect is usually expressed as a percentage of the phenotypic variance attributable to the locus.